DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Sai Parenterals Limited — Investor Presentation

NSE 2 hrs ago·12 Aug 2026, 8:34 am

SAIPARENT NSE

Sai Parenterals Limited has submitted its investor presentation to the stock exchange. This document typically outlines the company's future business strategies, financial projections, and operational roadmap for the upcoming period.

For investors, this update is a key opportunity to understand management's vision and gauge the company's growth trajectory. It helps in assessing whether the firm's plans align with market expectations and provides insight into its ability to execute.

Investors should watch for details regarding production capacity, export targets, and any commentary on raw material costs. These factors are critical for evaluating the company's potential to generate future returns.